Cargando…

Developing drugs against essential proteins of SARS-CoV-2 for the treatment of COVID-19

Detalles Bibliográficos
Autor principal:	Bajaj, Teena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biophysical Society. Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833095/ http://dx.doi.org/10.1016/j.bpj.2021.11.2667

Ejemplares similares

Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19
por: van de Leemput, Joyce, et al.
Publicado: (2021)

Candidate drugs against SARS-CoV-2 and COVID-19
por: McKee, Dwight L., et al.
Publicado: (2020)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Drug repurposing for SARS-CoV-2 (COVID-19) treatment
por: Mtewa, Andrew G., et al.
Publicado: (2022)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Recent progress in the development of potential drugs against SARS-CoV-2
por: Chen, Jianmin, et al.
Publicado: (2021)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2020)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2021)

Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity
por: Wu, Zhuanchang, et al.
Publicado: (2021)

Drug combination therapies for SARS-CoV-2 (COVID-19) treatment
por: Dable-Tupas, Genevieve, et al.
Publicado: (2022)

Drug Weaponry to Fight Against SARS-CoV-2
por: Cabezón, Elena, et al.
Publicado: (2020)

Phytochemicals against SARS-CoV as potential drug leads
por: Swain, Shasank Sekhar, et al.
Publicado: (2021)

Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection
por: Liu, Xiao-huan, et al.
Publicado: (2021)

Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
por: Abd El-Aziz, Tarek Mohamed, et al.
Publicado: (2020)

Current status of structure-based drug repurposing against COVID-19 by targeting SARS-CoV-2 proteins
por: Hijikata, Atsushi, et al.
Publicado: (2021)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Molecular insights into the inhibition mechanism of harringtonine against essential proteins associated with SARS-CoV-2 entry
por: Yang, Zhiwei, et al.
Publicado: (2023)

Computer-aided drug design against spike glycoprotein of SARS-CoV-2 to aid COVID-19 treatment
por: Shehroz, Muhammad, et al.
Publicado: (2020)

Essential Oil Disinfectant Efficacy Against SARS-CoV-2 Microbial Surrogates
por: Bailey, Emily S., et al.
Publicado: (2021)

Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19
por: Cui, Wen, et al.
Publicado: (2020)

Structure of SARS-CoV-2 membrane protein essential for virus assembly
por: Zhang, Zhikuan, et al.
Publicado: (2022)

An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
por: Drożdżal, Sylwester, et al.
Publicado: (2021)

Intensification of an Essential Tremor by SARS-CoV-2
por: Finsterer, Josef
Publicado: (2022)

Potential of Marine Terpenoids against SARS-CoV-2: An In Silico Drug Development Approach
por: Sahoo, Alaka, et al.
Publicado: (2021)

Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
por: Yin, Jialing, et al.
Publicado: (2022)

Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2
por: Ray, Manisha, et al.
Publicado: (2020)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Development of an Inactivated Vaccine against SARS CoV-2
por: Pavel, Shaikh Terkis Islam, et al.
Publicado: (2021)

The development of DNA vaccines against SARS-CoV-2
por: Khalid, Kanwal, et al.
Publicado: (2023)

Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19
por: Sharma, Homa Nath, et al.
Publicado: (2021)

Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021)

Anti-HIV drug repurposing against SARS-CoV-2
por: Sang, Peng, et al.
Publicado: (2020)

Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
por: Bobrowski, Tesia, et al.
Publicado: (2021)

Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’
por: Campesi, Ilaria, et al.
Publicado: (2021)

Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo
por: Weston, Stuart, et al.
Publicado: (2020)

DockCoV2: a drug database against SARS-CoV-2
por: Chen, Ting-Fu, et al.
Publicado: (2020)

The global battle against SARS-CoV-2 and COVID-19
por: Deng, Chu-Xia
Publicado: (2020)

Suggesting Ritonavir against COVID-19/SARS-CoV-2
por: Choudhury, Shuvasish, et al.
Publicado: (2020)

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
por: Huang, Yuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_489l6jg851tmn6us4cgjmu9nfv